Skip to main content
Fig. 7 | BMC Infectious Diseases

Fig. 7

From: Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment

Fig. 7

Diminished circulating levels of MMPs in KDM individuals on metformin treatment. (a) MMPs were measured in KDM individuals on metformin treatment versus no metformin treatment at baseline. (b) The plasma levels of MMPs were measured in KDM individuals on metformin treatment versus no metformin treatment at 6 months of ATT. The data are represented as scatter plots with each circle representing a single individual. P values were calculated using the Mann-Whitney test with Holm’s correction for multiple comparisons

Back to article page